HyundaiADM Bio (Co-CEOs Taek-Sung Kim and Kwang-Hee Kim) announced the results of its preclinical study on the oral anti-cancer drug OTX-M, developed from the well-known injectable chemotherapy drug docetaxel, at the “Biotech Showcase 2025” held in San Francisco from January 13 to 15. The company introduced a “new paradigm in cancer treatment,” shifting from intravenous […]

First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global alliance with a leading US medical institution and other organizations to harness technology for better patient care and outcomes in oncology. JelloXBiotech Inc., aTaiwan-based startup focused on cancer pathology, is unveiling its vision for AI and 3D digital

Digital Employee Experience (DEX) Leader Achieved Multiple Milestones and 30% Global ARR Growth LONDON, UK, AND AUSTIN, TX / ACCESSWIRE / January 22, 2025 / 1E, a leading Digital Employee Experience (DEX) platform company known for its scaled remediation and automation capabilities, today announced its 2024 results1. 1E exited 2024 with $79.3 million ARR. The

— DEWALT once again transforms the Las Vegas skyline with an electrifying activation on the exterior of Sphere — Unveils new “Built for the Unbreakable” campaign celebrating the strength of the men and women who work in the construction trades — Spotlights award-winning DEWALT POWERSHIFT™ System, a groundbreaking equipment system that optimizes the workflow of

(Paris:VK), VALLOUREC REDUCES ITS CARBON FOOTPRINT BY 19% IN 4 YEARS Meudon (France), January 22nd, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the result of its seamless tubes carbon footprint life cycle assessment. Based on 2023 data, Vallourec has reduced its carbon footprint to 1.45 tonnes of CO2 equivalent per

Sale of GOLIKE® Rights Outside the U.S. to NutrisensRelief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products GENEVA, SWITZERLAND / ACCESSWIRE / January 22, 2025 / RELIEF THERAPEUTICS Holding SA(SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today

Vallourec reduces its carbon footprint by 19% in 4 years GlobeNewswire January 22, 2025 VALLOUREC REDUCES ITS CARBON FOOTPRINT BY 19% IN 4 YEARS Meudon (France), January 22nd, 2025 – Vallourec, a world leader in premium seamless tubular solutions, announces the result of its seamless tubes carbon footprint life cycle assessment. Based on 2023 data,

Report with market evolution powered by AI – The education market in UAEsize is estimated to grow by USD 5.1 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 8.6% during the forecast period. Increasing student enrollmentsis driving market growth,with a trend towardsrising awareness of early education. However,increased

Delivers Authentic Listening Experience by Expressing Three Elements of Spatial Reverberation, Quietness, and Dynamic Range While Preserving Natural “Texture” of Musical Instruments – ROHM has developed a 32-bit D/A converter IC (DAC chip) and an evaluation board for flagship models in its MUS-IC (TM) series, optimized for high-resolution audio playback. DAC chips are key to

(Paris:SAN), Sarclisa approved in the EU as the first anti-CD38 therapy in combination with standard-of-care VRd to treat transplant-ineligible newly diagnosed multiple myeloma Approval is based on positive results from the IMROZ phase 3 study, demonstrating Sarclisa in combination with standard-of-care treatment significantly improved PFS, compared to the standard of care alone in TI NDMM